Your cart is currently empty!
Also known as Central Pontine Myelinolysis.
The most common subtype of Guillain-Barré Syndrome (GBS).
Characterized by multifocal inflammation and demyelination following infection or vaccination.
Also known as Hereditary Motor and Sensory Neuropathy.
Characterized by demyelination in the CNS due to oligodendrocyte destruction.
Disorder | Key Features | Common Symptoms and Risks | Treatment/Management |
---|---|---|---|
Osmotic Demyelination Syndrome | Caused by rapid osmotic shifts; can result in “locked-in syndrome” | Paralysis, dysarthria, dysphagia, consciousness loss | Avoid rapid Na⁺ correction |
Acute Inflammatory Demyelinating Polyradiculopathy (AIDP) | Autoimmune demyelination of peripheral nerves; a subtype of Guillain-Barré syndrome | Ascending weakness, respiratory failure, autonomic issues | Plasmapheresis or IV immunoglobulins |
Acute Disseminated Encephalomyelitis | Postinfectious or postvaccination multifocal inflammation and demyelination | Rapid neurologic deterioration, altered mental status | Supportive care |
Charcot-Marie-Tooth Disease | Hereditary nerve disorder, typically autosomal dominant, affecting myelin proteins | Foot deformities, lower extremity weakness, sensory deficits | Symptomatic management |
Progressive Multifocal Leukoencephalopathy (PML) | CNS demyelination due to JC virus, affecting immunocompromised individuals | Visual disturbances, progressive neurologic decline | No specific treatment; avoid natalizumab if at risk |